A 2-Week, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan in Combination With Hydrochlorothiazide in Patients With Mild to Moderate Hypertension
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2016
Price : $35 *
At a glance
- Drugs Fimasartan (Primary) ; Hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Boryung Pharmaceutical
- 30 Jun 2016 Status changed from recruiting to completed.
- 14 Oct 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 25 Aug 2014 New trial record